Integrative Health Technologies, Inc. (IHTI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Integrative Health Technologies, Inc. (IHTI) trades at $0.00. Integrative Health Technologies, Inc. provides clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries. Market cap: $1,626, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for IHTI: IHTI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IHTI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IHTI: 1/1 perspectives are bearish.
How is this calculated? →Integrative Health Technologies, Inc. (IHTI) Healthcare & Pipeline Overview
Integrative Health Technologies provides specialized clinical trial, research, and consulting services within the healthcare and nutritional sectors. Its database of over 30,000 tests spanning two decades and DEXA scanning services position it as a niche player in diagnostics and research, serving healthcare providers and nutritional companies.
What Is the Investment Thesis for IHTI?
Integrative Health Technologies operates in the niche area of diagnostics and research, offering specialized services to the healthcare and nutritional industries. With a market capitalization of 2K, the company's financial performance reflects a profit margin of 8.6% and a gross margin of 17.3%. Key value drivers include its proprietary database of over 30,000 tests and its DEXA scanning services. Growth catalysts include expanding its clinical trial services and leveraging its database for further research and development. Potential risks include competition from larger diagnostic companies and the need to maintain regulatory compliance. The company's beta of -0.03 suggests low volatility relative to the market. The absence of a dividend may deter some investors seeking income.
Based on FMP financials and quantitative analysis
IHTI Key Highlights
- Proprietary database containing over 30,000 tests spanning 20 years, offering a unique research asset.
- Operation of mobile and stationary DEXA units for body composition scanning, providing specialized diagnostic services.
- Blood chemistry testing report including 43 chemistries, offering comprehensive health insights.
- Profit margin of 8.6% indicates profitability in its specialized service offerings.
- Gross margin of 17.3% reflects the company's ability to generate revenue from its services.
Who Are IHTI's Competitors?
IHTI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| PRE Prenetics Global Limited | $17.25 | +1.88% | $293.23M | 69 |
| EPGNY Epigenomics AG | $2.39 | +0.00% | 68 | |
| STRRP Star Equity Holdings, Inc. | $9.89 | -0.10% | $40.58M | 68 |
| TWST Twist Bioscience Corporation | $100.97 | +1.74% | $6.29B | 65 |
| CNTG Centogene N.V. | $0.33 | +100.00% | $9.42M | 50 |
| NVTA Invitae Corporation | $0.02 | -35.59% | $5.44M | 50 |
| ICLR ICON Public Limited Company | $170.94 | -1.23% | $13.09B | 50 |
| ME 23andMe Holding Co. | $0.61 | +100.00% | $15.31M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IHTI's Key Strengths?
- Proprietary database of over 30,000 tests.
- Specialized expertise in DEXA scanning services.
- Established relationships with healthcare and nutritional companies.
- Focus on niche markets within the broader healthcare industry.
What Are IHTI's Weaknesses?
- Small market capitalization limits access to capital.
- Limited brand recognition compared to larger diagnostic companies.
- Dependence on fee-based services may be vulnerable to economic downturns.
- OTC market listing may limit investor interest.
What Could Drive IHTI Stock Higher?
- Expansion of clinical trial services to pharmaceutical and biotechnology companies.
- Leveraging proprietary database for research and development partnerships.
- Potential new partnerships with nutritional companies to provide testing and analysis services.
- Development and launch of new diagnostic tests for specific diseases and conditions.
- Geographic expansion of DEXA scanning services.
What Are the Key Risks for IHTI?
- Financial-distress signal — its Altman Z-Score of 0.64 sits in the distress zone (elevated bankruptcy risk).
- Competition from larger diagnostic companies with greater resources.
- Changes in healthcare regulations and reimbursement policies.
- Technological advancements that could render existing services obsolete.
- Economic downturns that could reduce demand for fee-based services.
- Limited financial disclosure due to OTC market listing.
What Are the Growth Opportunities for IHTI?
- Expansion of Clinical Trial Services: Integrative Health Technologies can capitalize on the growing demand for clinical trials by expanding its service offerings to pharmaceutical and biotechnology companies. The global clinical trials market is projected to reach $69.7 billion by 2028, offering a significant growth opportunity. By leveraging its expertise in data analysis and testing, the company can attract new clients and increase its revenue stream. Timeline: Ongoing.
- Leveraging Proprietary Database for Research and Development: The company's database of over 30,000 tests represents a valuable asset for research and development. Integrative Health Technologies can partner with research institutions and pharmaceutical companies to conduct studies and develop new diagnostic tools. This can generate revenue through licensing agreements and research grants. The market for healthcare data analytics is expected to grow significantly in the coming years. Timeline: Ongoing.
- Geographic Expansion of DEXA Scanning Services: Integrative Health Technologies can expand its DEXA scanning services to new geographic markets. The demand for body composition analysis is increasing due to growing awareness of health and fitness. By establishing new mobile and stationary DEXA units in underserved areas, the company can tap into new customer segments and increase its revenue. Timeline: 1-2 years.
- Development of New Diagnostic Tests: Integrative Health Technologies can invest in the development of new diagnostic tests to expand its service offerings. This can include tests for specific diseases or conditions, as well as personalized medicine approaches. By staying at the forefront of diagnostic innovation, the company can attract new clients and increase its market share. Timeline: 2-3 years.
- Strategic Partnerships with Nutritional Companies: Integrative Health Technologies can form strategic partnerships with nutritional companies to provide testing and analysis services for their products. This can include testing for nutrient content, bioavailability, and efficacy. By collaborating with nutritional companies, the company can tap into the growing market for health and wellness products. Timeline: Ongoing.
What Opportunities Does IHTI Have?
- Expansion of clinical trial services to pharmaceutical and biotechnology companies.
- Leveraging proprietary database for research and development partnerships.
- Geographic expansion of DEXA scanning services.
- Development of new diagnostic tests for specific diseases and conditions.
What Threats Does IHTI Face?
- Competition from larger diagnostic companies with greater resources.
- Changes in healthcare regulations and reimbursement policies.
- Technological advancements that could render existing services obsolete.
- Economic downturns that could reduce demand for fee-based services.
What Are IHTI's Competitive Advantages?
- Proprietary database of over 30,000 tests provides a unique research asset.
- Specialized expertise in DEXA scanning services offers a competitive advantage.
- Long-standing relationships with healthcare and nutritional companies create customer loyalty.
- Focus on niche markets within the broader healthcare industry allows for specialization and differentiation.
What Does IHTI Do?
Integrative Health Technologies, Inc., founded in 1999 and based in San Antonio, Texas, operates within the healthcare sector, offering a suite of fee-based clinical trials, research and development, consulting, and testing services. The company caters to both the healthcare and nutritional industries, providing specialized support and data analysis. A key asset is its proprietary database, which contains over 30,000 tests and spans more than 20 years, tracking the footprints of various diseases. This historical data provides a valuable resource for research and development initiatives. In addition to its data services, Integrative Health Technologies operates both mobile and stationary dual energy x-ray absorptiometry (DEXA) body composition scanning units. These units are used to measure total body and regional bone densities, as well as body fat and lean mass. This service is valuable for assessing overall health and fitness, as well as for monitoring the effects of various treatments and interventions. The company also provides a comprehensive blood chemistry testing report, which includes 43 chemistries, such as HDL, LDL, C-reactive protein, thyroid, electrolytes, red and white blood cell counts, and glucose levels. This report offers a detailed overview of a patient's health status, aiding in diagnosis and treatment planning. Integrative Health Technologies focuses on providing specialized services and data analysis to support the healthcare and nutritional industries.
What Products and Services Does IHTI Offer?
- Provides fee-based clinical trials to healthcare companies.
- Offers research and development services to the healthcare industry.
- Delivers consulting services to healthcare and nutritional companies.
- Conducts testing services for healthcare and nutritional industries.
- Maintains a database of over 30,000 tests tracking disease footprints.
- Operates mobile and stationary DEXA body composition scanning units.
- Provides blood chemistry testing reports with 43 chemistries.
How Does IHTI Make Money?
- Generates revenue through fee-based clinical trials.
- Earns income from research and development services.
- Receives payments for consulting services provided to healthcare and nutritional companies.
- Charges fees for testing services, including blood chemistry and DEXA scans.
What Industry Does IHTI Operate In?
Integrative Health Technologies operates within the medical diagnostics and research industry, a sector characterized by continuous innovation and increasing demand for specialized testing and analysis. The industry is driven by factors such as an aging population, rising prevalence of chronic diseases, and advancements in medical technology. The competitive landscape includes larger diagnostic companies, as well as specialized research and testing firms. Integrative Health Technologies differentiates itself through its proprietary database and DEXA scanning services, targeting niche markets within the broader healthcare and nutritional industries.
Who Are IHTI's Key Customers?
- Healthcare companies seeking clinical trial services.
- Nutritional companies requiring testing and analysis of their products.
- Research institutions partnering on research and development projects.
- Individuals seeking body composition analysis through DEXA scans.
Company Profile
Integrative Health Technologies, Inc. operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in San Antonio, US. The company is led by CEO Gilbert R. Kaats. IHTI has traded publicly since 2002.
F-Score 4/9Financial Health
Integrative Health Technologies, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.64 places it in the distress zone, a signal of elevated financial risk.
ROE 0%Key Financial Metrics
Return on equity for Integrative Health Technologies, Inc. stands at 0.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.5%, showing how much profit it generates from its asset base. A current ratio of 0.09 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
IHTI Valuation & Market Position
With a 2K market cap, Integrative Health Technologies, Inc. sits in the micro-cap segment of the market.
IHTI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary database of over 30,000 tests.
- Specialized expertise in DEXA scanning services.
- Established relationships with healthcare and nutritional companies.
- Focus on niche markets within the broader healthcare industry.
Bear Case
- Small market capitalization limits access to capital.
- Limited brand recognition compared to larger diagnostic companies.
- Dependence on fee-based services may be vulnerable to economic downturns.
- OTC market listing may limit investor interest.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IHTI Latest News
No recent news available for IHTI.
IHTI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IHTI.
Price Targets
Wall Street price target analysis for IHTI.
IHTI MoonshotScore
What does this score mean?
The MoonshotScore rates IHTI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Gilbert R. Kaats
CEO
Gilbert R. Kaats serves as the CEO of Integrative Health Technologies, Inc. His background includes experience in the healthcare and nutritional industries. He has been involved in the development and implementation of various diagnostic and research services. His expertise lies in the areas of clinical trials, data analysis, and body composition assessment. He has a strong understanding of the regulatory landscape and market dynamics within the healthcare sector.
Track Record: Under Gilbert R. Kaats' leadership, Integrative Health Technologies has focused on expanding its service offerings and leveraging its proprietary database. He has overseen the development of new diagnostic tests and the expansion of DEXA scanning services. He has also worked to establish strategic partnerships with healthcare and nutritional companies. Specific achievements and milestones are not available in the provided data.
IHTI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Integrative Health Technologies may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies on this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure may make it difficult to assess the company's financial health.
- Lower liquidity can lead to wider bid-ask spreads and greater price volatility.
- OTC market listing may limit investor interest and access to capital.
- Potential for delisting or suspension of trading due to non-compliance with OTC regulations.
- Increased risk of fraud or manipulation compared to exchange-listed stocks.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Analyze the company's revenue streams and profitability.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Consult with a financial advisor before investing.
- Operation since 1999 suggests some level of business viability.
- Focus on clinical trials and research indicates involvement in regulated industries.
- Proprietary database and DEXA scanning services suggest specialized expertise.
- CEO with experience in the healthcare and nutritional industries.
- Physical headquarters in San Antonio, Texas.
IHTI Healthcare Stock FAQ
What does Integrative Health Technologies, Inc. do?
Integrative Health Technologies, Inc. provides specialized clinical trials, research and development, consulting, and testing services to the healthcare and nutritional industries. The company maintains a database of over 30,000 tests spanning more than 20 years, tracking disease footprints. It also operates mobile and stationary DEXA units for body composition scanning and provides comprehensive blood chemistry testing reports. These services cater to healthcare providers, nutritional companies, and research institutions, offering valuable data and diagnostic capabilities.
What are the main risks for IHTI?
The main risks for Integrative Health Technologies include competition from larger diagnostic companies, potential changes in healthcare regulations, and technological advancements that could render existing services obsolete. As an OTC-listed company, IHTI faces additional risks related to limited financial disclosure, lower liquidity, and potential for delisting. Economic downturns could also reduce demand for its fee-based services. Investors should carefully consider these risks before investing in IHTI.
What are the key factors to evaluate for IHTI?
Evaluate IHTI on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does IHTI data refresh on this page?
IHTI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IHTI's recent stock price performance?
Integrative Health Technologies, Inc. (IHTI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary database of over 30,000 tests. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IHTI overvalued or undervalued right now?
Valuing Integrative Health Technologies, Inc. (IHTI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IHTI?
Before investing in Integrative Health Technologies, Inc. (IHTI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding IHTI to a portfolio?
Key strength of Integrative Health Technologies, Inc. (IHTI): Proprietary database of over 30,000 tests. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC market listing.
- Analyst consensus and valuation metrics are unavailable.
- OTC analysis based on general characteristics of the OTC Other tier.